| Zydus Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532321 |
NSE Symbol : ZYDUSLIFE |
P/E(TTM) : 24.31 |
|
ISIN Demat : INE010B01027 |
Div & Yield% : 0.28 |
EPS(TTM) : 43.41 |
|
Book Value(₹) : 156.19 |
Market Cap(₹Cr) : 106,197.94 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 4,035.40 | 3,172.60 | 2,225.10 | 2,050.00 | 2,869.90 | 2,437.30 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 4,035.40 | 3,172.60 | 2,225.10 | 2,050.00 | 2,869.90 | 2,437.30 |
| Other Operating Income | 124.80 | 159.80 | 146.20 | 109.30 | 85.80 | 142.00 |
| Other Income | 106.60 | 361.10 | 106.80 | 534.50 | 82.40 | 251.20 |
| Total Income | 4,266.80 | 3,693.50 | 2,478.10 | 2,693.80 | 3,038.10 | 2,830.50 |
| Total Expenditure | 1,787.30 | 1,771.80 | 1,672.20 | 1,509.90 | 1,814.70 | 2,010.60 |
| PBIDT | 2,479.50 | 1,921.70 | 805.90 | 1,183.90 | 1,223.40 | 819.90 |
| Interest | 115.40 | 106.20 | 103.90 | 90.90 | 89.70 | 85.00 |
| PBDT | 2,364.10 | 1,815.50 | 702.00 | 1,093.00 | 1,133.70 | 734.90 |
| Depreciation | 130.60 | 130.60 | 127.70 | 124.90 | 121.20 | 119.90 |
| Tax | 531.60 | 407.50 | 118.80 | 171.60 | 236.40 | 129.60 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.10 | -127.80 | 5.10 | -8.50 | -4.80 | -5.30 |
| Reported Profit After Tax | 1,700.80 | 1,405.20 | 450.40 | 805.00 | 780.90 | 490.70 |
| Extra-ordinary Items | 0.00 | -6.52 | 0.00 | 0.00 | 0.00 | -160.85 |
| Adjusted Profit After Extra-ordinary item | 1,700.80 | 1,411.72 | 450.40 | 805.00 | 780.90 | 651.55 |
| EPS (Unit Curr.) | 16.90 | 13.89 | 4.45 | 7.96 | 7.71 | 4.85 |
| EPS (Adj) (Unit Curr.) | 16.90 | 13.89 | 4.45 | 7.96 | 7.71 | 4.85 |
| Calculated EPS (Unit Curr.) | 16.91 | 13.97 | 4.45 | 7.95 | 7.72 | 4.85 |
| Calculated EPS (Adj) (Unit Curr.) | 16.91 | 13.97 | 4.45 | 7.95 | 7.72 | 4.85 |
| Calculated EPS (Ann.) (Unit Curr.) | 67.63 | 55.87 | 17.80 | 31.82 | 30.87 | 19.40 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 67.63 | 55.87 | 17.80 | 31.82 | 30.87 | 19.40 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 100.60 | 100.60 | 101.20 | 101.20 | 101.20 | 101.20 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 61.44 | 60.57 | 36.22 | 57.75 | 42.63 | 33.64 |
| PBDTM(%) | 58.58 | 57.22 | 31.55 | 53.32 | 39.50 | 30.15 |
| PATM(%) | 42.15 | 44.29 | 20.24 | 39.27 | 27.21 | 20.13 |